Q3 2024 Nutex Health Inc Earnings Call Transcript
Key Points
- Nutex Health Inc (NUTX) reported a significant revenue growth of 26% in the third quarter of 2024, reaching $78.8 million compared to $62.7 million in the same period last year.
- The company achieved a substantial increase in adjusted EBITDA, which rose by 938% to $13.5 million from $1.3 million in the previous year.
- Nutex Health Inc (NUTX) successfully opened four new hospitals in 2023, contributing to the positive revenue trend and demonstrating effective expansion strategies.
- The hospital division saw a 11.3% increase in patient visits, indicating strong demand and effective patient engagement strategies.
- Operational efficiency improvements led to a gross profit increase of 210% in the third quarter of 2024 compared to the same period in 2023.
- Nutex Health Inc (NUTX) reported a net loss of $8.8 million for the third quarter of 2024, which is higher than the $5.5 million loss in the same quarter of 2023.
- The company faced a $6.7 million non-cash loss on warrant liability and a $2 million non-cash stock-based compensation expense, impacting net income negatively.
- Population Health Management division experienced a revenue decline due to the divestiture of two smaller entities, affecting the overall revenue mix.
- Finance lease liabilities increased from $213 million to $241 million, primarily due to new leases for recently opened facilities.
- Challenges with the No Surprises Act (NSA) claims and arbitration processes continue to impact reimbursement rates and financial outcomes.
Greetings and welcome to Nutex Health Inc third quarter, 2024 financial results conference call at this time, all participants are in a listen-only mode, a question and answer session will follow the formal presentation. (Operator instruction). It is now my pleasure to introduce your host, Vivian Sanders. Thank you. You may begin.
Good morning and welcome to New Tech Health Inc third quarter earnings call for the period ended September 30th 2024. My name is Vivian Sanders and I will be your moderator for today's call. We appreciate your participation and interest in our company. Today's call is being recorded. With me this morning is our Chairman and CEO, Dr. Tom Vo, CFO, Jon Bates; President, Dr. Warren Hosseinion; and COO, Josh DeTillio. Our team will provide some prepared remarks and then we'll take questions.
Before I turn the call over to Dr. Vo, let me remind everyone that today's call may contain forward-looking statements that are based on management's current
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
